No. You are reading it incorrectly. Patients are considered cured of HCV if they have undetectable virus levels 12 weeks after dose completion (SVR12). For these trials this won't be until mid August for the G3 cohort and Feb 2016 for the G1 cohort. This means more waiting.
Ann: Independent review supports development of BIT225, page-6
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
-0.011(39.3%) |
Mkt cap ! $15.33M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.5¢ | 1.7¢ | $374.7K | 18.97M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 1266038 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 689330 | 2 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |